United Therapeutics (UTHR) Goodwill (2010 - 2025)

United Therapeutics has disclosed Goodwill across 16 years of filings, most recently posting $32.3 million for Q4 2025.

• Goodwill for Q4 2025 came in at $32.3 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $32.3 million (changed 0.0% YoY), and the FY2025 annual result was $32.3 million, changed 0.0% from the prior year.
• Goodwill came in at $32.3 million for Q4 2025 at United Therapeutics, roughly flat from $32.3 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $33.7 million in Q4 2023 to a low of $4.3 million in Q3 2024.
• The 5-year median for Goodwill is $28.0 million (2021), against an average of $27.2 million.
• Across the five-year window, Goodwill increased 20.36% in 2023 and slipped 4.15% in 2024, its largest moves.
• United Therapeutics' Goodwill stood at $28.0 million in 2021, then changed by 0.0% to $28.0 million in 2022, then gained by 20.36% to $33.7 million in 2023, then dropped by 4.15% to $32.3 million in 2024, then changed by 0.0% to $32.3 million in 2025.
• The last three Goodwill figures came in at $32.3 million (Q4 2025), $32.3 million (Q4 2024), and $4.3 million (Q3 2024), per Business Quant data.